Pregnancy incidence and correlates during the HVTN 503 phambili HIV vaccine trial conducted among south african women

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Latka, Mary H ^a   Fielding, Katherine ^b   Gray, Glenda E ^c   Bekker, Linda Gail ^d   Nchabeleng, Maphoshane ^e   Mlisana, Koleka ^f   Nielson, Tanya ^a   Roux, Surita ^d   Mkhize, Baningi ^c   Mathebula, Matsontso ^e   Naicker, Nivashnee ^f   de Bruyn, Guy ^c   Kublin, James ^g   Churchyard, Gavin J ^a  

^a AURUM INSTITUTE   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

^f UNIVERSITY OF KWAZULU NATAL   (South Africa)

^g USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INJECTABLE CONTRACEPTIVE AGENT; ORAL CONTRACEPTIVE AGENT;

ADULT; ALCOHOLISM; ARTICLE; CANNABIS SMOKING; COHORT ANALYSIS; CONDOM; CONTRACEPTION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRINKING BEHAVIOR; DRUG SAFETY; ECTOPIC PREGNANCY; FEMALE; FETUS DEATH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PHASE 3 CLINICAL TRIAL; PREGNANCY OUTCOME; PREGNANCY RATE; PREGNANCY TEST; PREMATURE LABOR; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SCREENING TEST; SELECTIVE ABORTION; SOUTH AFRICA; SPONTANEOUS ABORTION; STILLBIRTH; TERM BIRTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; PREGNANCY; SEXUAL BEHAVIOR; STATISTICS;

CANNABIS SATIVA;

ADULT; AIDS VACCINES; CONTRACEPTION BEHAVIOR; FEMALE; HIV INFECTIONS; HUMANS; PREGNANCY; PREGNANCY RATE; SOUTH AFRICA;

EID: 84859855349     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031387     Document Type: Article

References (19)

1. Skoler S, Peterson L, Cates W, (2006) Our current microbicide trials: Lessons learned and to be learned Microbicide Q 1: 1-6.
2. Peterson L, Nanda K, Opoku BK, Ampofo WK, Owusu-Amoako M, et al. (2007) SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana PLoS One 2: 1312.
3. Raymond EG, Taylor D, Cates W, Tolley EE, Borasky D, et al. (2007) Pregnancy in effectiveness trials of HIV prevention agents Sex Transm Dis 34: 1035-1039.
4. Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, et al. (2007) Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial Lancet 370: 251-261.
5. Skoler-Karpoff S, Ramjee G, Ahmed K, Altini L, Plagianos M, et al. (2008) Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial The Lancet 372: 1977-1987.
6. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, et al. (2011) Effectiveness and safety of tenofovir gel, an antiretroviral microbicide for the prevention of HIV infection in women Science 329: 1168-1174.
7. Reid SE, Dai JY, Wang J, Sichalwe BN, Akpomiemie G, et al. (2010) Pregnancy, contraceptive use, and HIV acquisition in HPTN039: Relevance for HIV prevention trials among African women JAIDS 53: 606-613.
8. Halpern V, Lie CC, Felblum P, VanDamme L, (2011) Predictors of pregnancy in microbicide trials Contraception 83: 436-440.
9. Cao H, Kaleebu P, Horn D, Flores J, Agrawal D, et al. (2003) Immunogenicity of a recombinant human immunodeficiency virus (HIV)-canarypox vaccine in HIV-seronegative Ugandan volunteers: Results of the HIV Network for Prevention Trials 007 Vaccine Study. J Infec Dis 187: 887-895.
10. Kibuuka H, Guwatudde D, Kimutai R, Maganga L, Maboko L, (2009) Contraceptive use in women enrolled into preventive HIV vaccine trials: experience form a phase I/II trial in East Africa PLoS ONE 4: 1-6.
11. Pitisuttithum P, Rerks-Ngarm S, Kaewkungwal I, Nitayaphan S, Khamboonruang C, et al. (2009) Recruitment, retention and participation impact events among women participating in phase III community trial in Thailand AIDS Vaccine Conference, Paris France. Poster abstract # 193.
12. Rerks-Ngarm S, Pitisuttitithum P, Nitayaphan S, Kaewkungwal J, Chiu J, et al. (2009) Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand New Eng J Med 361: 1-12.
13. Sibeko S, Baxter C, Yende N, Abdool Karim Q, Abdool Karim SS, (2011) Contraceptive Choices, Pregnancy Rates and Outcomes in a Microbicide Trial Obstet Gynecol 118: 895-904.
14. Gray GE, Allen M, Moodie Z, Churchyard G, Bekker LG, et al. (2011) Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study Lancet Infect Dis 11: 507-515.
15. Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Robin Mogg R, et al. (2008) Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial Lancet 372: 1881-1893.
16. Ramjee G, Kapiga S, Weiss S, Peterson L, Leburg C, et al. (2008) The value of site preparedness studies for future implementation of phase 2/Ilb/Ill HIV prevention trials: Experience from the HPTN 055 Study JAIDS 47: 93-100.
17. Vallely A, Hambleton IR, Kasindi S, Knight L, Francis SC, et al. (2010) Are women who work in bars, guesthouses and similar facilities a suitable study population for vaginal microbicide trials in Africa? PLoS One 5: 1-9.
18. Bello B, Kielkowski D, Heederik D, Wilson K, (2010) Time-to-pregnancy and pregnancy outcomes in a South African population BMC Pub Health 10: 565.
19. Shisana O, Rehle T, Simbayi LC, Zuma K, Jooste S, et al. (2009) South African national HIV prevalence, incidence, behaviour and communication survey 2008: A turning tide among teenagers? Cape Town HSRC Press.